When will determine the nature and extent of any type of cancer, including
mesothelioma, Oncology experts will apply a rubric or a system of
"staging", who was instrumental in designing the right course to
treat sufferers of mesothelioma patients. This is just one of the criteria of
malignancy are classified; the first is determined by the position of the tumor
and the third is determined by the structure of the provider.
The staging will also help oncologists in determining the extent to which
the development of mesothelioma and realistic level treatability malignancy
patients.
Although the three staging systems currently in use are different, but the
third play is based on four main stages:
- The tumor is confined to one area or organ, and relatively small. (Stage 1 Mesothelioma)
- The size of the tumor has grown and has spread to one of the other networks. (Stage 2 Mesothelioma)
- The tumor has spread to the surrounding area. (Stage 3 Mesothelioma)
- The tumor has spread to distant areas of the body or "metastasis." (Stage 4 Mesothelioma)
Stage 2 Mesothelioma Prognosis
In most cases, mesothelioma cannot be detected until you reach stage 3 or
stage 4, which at the time of the drug or mesothelioma mesothelioma remission
is not possible and all you can do is attempt to make patients feel more
comfortable.
The latest diagnostic tests MESOMARK ™ can allow the expert pathologists to detect the disease at an early stage. Recently, the FDA approved for use in the United States, this test has been developed by an American biotech firms and Japan reportedly able to detect biological symptoms of early malignant mesothelioma. In stage 1, tumor usually can be removed through surgery mesothelioma; mesothelioma chemotherapy and radiation treatments are used to follow up to eradicate traces of malignancy.